MedPath
Found 27 clinical trials|View Analysis
Sort by:

Preoperative Partial Breast Reirradiation and Repeat Breast-conserving Surgery in Patients With Recurrent Breast Cancer: the REPEAT Trial

Phase 2
Recruiting
Conditions
Recurrent Breast Carcinoma
Ipsilateral Recurrence
First Posted Date
2024-10-15
Last Posted Date
2024-12-11
Lead Sponsor
Amsterdam UMC, location VUmc
Target Recruit Count
25
Registration Number
NCT06640881
Locations
🇳🇱

Amsterdam UMC / VU Medical Centre, Amsterdam, Netherlands

Reirradiation Dose Escalation in Thoracic Cancers

Phase 1
Not yet recruiting
Conditions
Thoracic Cancer
Lung Cancer
Esophageal Cancer
Interventions
Radiation: stereotactic body radiation therapy (SBRT)
First Posted Date
2024-08-16
Last Posted Date
2024-08-16
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
48
Registration Number
NCT06558175

Ablative Stereotactic MR-Guided Adaptive Reirradiation

Not Applicable
Recruiting
Conditions
Abdominal Cancer
Pelvic Cancer
Interventions
Radiation: Reirradiation
First Posted Date
2024-05-03
Last Posted Date
2024-12-10
Lead Sponsor
Baptist Health South Florida
Target Recruit Count
10
Registration Number
NCT06397573
Locations
🇺🇸

Miami Cancer Institute at Baptist Health South Florida, Miami, Florida, United States

Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

Phase 3
Recruiting
Conditions
First Progression of Glioblastoma
Interventions
Drug: Lomustine
Radiation: Reirradiation
First Posted Date
2023-06-15
Last Posted Date
2025-01-03
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
411
Registration Number
NCT05904119
Locations
🇩🇰

Aarhus University Hospitals - Region Midtjylland - Aarhus University Hospital-Skejby, Aarhus, Denmark

🇩🇪

Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern, Munich, Germany

🇦🇹

A.O Landeskrankenhaus - Innsbruck Universitaetsklinik, Innsbruck, Austria

and more 26 locations

Reirradiation and Niraparib in Patients With Recurrent Glioblastoma

Phase 1
Withdrawn
Conditions
Recurrent Glioblastoma
Interventions
Drug: Niraparib
Radiation: Re-irradiation (re-RT)
First Posted Date
2022-12-27
Last Posted Date
2024-03-26
Lead Sponsor
University College, London
Registration Number
NCT05666349

Prostate Reirradiation Toxicity Outcomes Feasibility Study

Not Applicable
Not yet recruiting
Conditions
Prostate Cancer
Radiotherapy Side Effect
Interventions
Radiation: Brachytherapy
Radiation: Sterotactic Body Radiotherapy
First Posted Date
2022-11-14
Last Posted Date
2022-11-15
Lead Sponsor
University of Leeds
Target Recruit Count
60
Registration Number
NCT05614700

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

Recruiting
Conditions
Stereotactic Body Radiation Therapy
Irradiation; Reaction
Recurrent Cancer
Thoracic Tumor
First Posted Date
2022-01-12
Last Posted Date
2023-12-27
Lead Sponsor
Peking University Third Hospital
Target Recruit Count
40
Registration Number
NCT05189054
Locations
🇨🇳

Peking University Third Hospital, Beijing, Beijing, China

Nanoparticles and Hypofractionated Protontherapy for Reirradiation of Pantumor Relapse

Phase 2
Not yet recruiting
Conditions
Recurrent Cancer
Previous Radiation
Interventions
Radiation: Radiation by protontherapy associated to nanoparticles injection
First Posted Date
2021-03-05
Last Posted Date
2023-07-27
Lead Sponsor
Centre Francois Baclesse
Target Recruit Count
46
Registration Number
NCT04784221

Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

Phase 1
Recruiting
Conditions
Prostate Cancer
Interventions
Drug: Metformin
Radiation: Stereotactic Body Radiation Therapy (SBRT) 30 Gray (Gy)
Radiation: Stereotactic Body Radiation Therapy (SBRT) 36 Gy
Radiation: Stereotactic Body Radiation Therapy (SBRT) 25 Gy
First Posted Date
2020-09-03
Last Posted Date
2024-03-13
Lead Sponsor
Institut Cancerologie de l'Ouest
Target Recruit Count
44
Registration Number
NCT04536805
Locations
🇫🇷

Institut de Cancerologie de L'Ouest, Saint Herblain, France

🇫🇷

Centre OSCAR LAMBRET, Lille, France

🇫🇷

Clinique Victor Hugo, Le Mans, France

and more 8 locations

SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions

Not Applicable
Recruiting
Conditions
Non Small Cell Lung Cancer
Lung Metastases
Interventions
Radiation: SBRT dose escalation
First Posted Date
2020-07-02
Last Posted Date
2022-09-15
Lead Sponsor
Istituto Clinico Humanitas
Target Recruit Count
15
Registration Number
NCT04455438
Locations
🇮🇹

Humanitas Research Hospital, Rozzano, Milano, Italy

© Copyright 2025. All Rights Reserved by MedPath